Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brough

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Iscience|February 8, 2024
Brazilin is a natural product inhibitor of the NLRP3 inflammasomeEmily McMahon, Sherihan El-Sayed, Jack Green, et al.
Plos Pathogens|April 13, 2019
Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosaBrian J McHugh, Rongling Wang, Hsin-Ni Li, et al.
Science Advances|May 17, 2024
Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survivalMichael J Haley, Leoma Bere, James Minshull, et al.
Scientific Reports|April 6, 2018
Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responsesElena Redondo-Castro, Dorte Faust, Simon Fox, et al.
Brain Communications|September 8, 2023
The comparable tumour microenvironment in sporadic and <i>NF2</i>-related schwannomatosis vestibular schwannomaGrace E Gregory, Adam Paul Jones, Michael J Haley, et al.
Nature Immunology|June 23, 2014
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory responseAlberto Baroja-Mazo, Fatima Martín-Sánchez, Ana I Gomez, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma MicroenvironmentCathal J Hannan, Daniel Lewis, Claire O'Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2018
Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malariaPatrick Strangward, Michael J Haley, Manuel G Albornoz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2019
Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the LungAlistair L Chenery, Rafid Alhallaf, Zainab Agha, et al.
Nature Communications|March 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannomaAdam P Jones, Michael J Haley, Miriam H Meadows, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Iscience|February 8, 2024
Brazilin is a natural product inhibitor of the NLRP3 inflammasomeEmily McMahon, Sherihan El-Sayed, Jack Green, et al.
Plos Pathogens|April 13, 2019
Cathelicidin is a "fire alarm", generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosaBrian J McHugh, Rongling Wang, Hsin-Ni Li, et al.
Science Advances|May 17, 2024
Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survivalMichael J Haley, Leoma Bere, James Minshull, et al.
Scientific Reports|April 6, 2018
Development of a characterised tool kit for the interrogation of NLRP3 inflammasome-dependent responsesElena Redondo-Castro, Dorte Faust, Simon Fox, et al.
Brain Communications|September 8, 2023
The comparable tumour microenvironment in sporadic and <i>NF2</i>-related schwannomatosis vestibular schwannomaGrace E Gregory, Adam Paul Jones, Michael J Haley, et al.
Nature Immunology|June 23, 2014
The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory responseAlberto Baroja-Mazo, Fatima Martín-Sánchez, Ana I Gomez, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 14, 2022
Beyond Antoni: A Surgeon's Guide to the Vestibular Schwannoma MicroenvironmentCathal J Hannan, Daniel Lewis, Claire O'Leary, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2018
Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malariaPatrick Strangward, Michael J Haley, Manuel G Albornoz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2019
Inflammasome-Independent Role for NLRP3 in Controlling Innate Antihelminth Immunity and Tissue Repair in the LungAlistair L Chenery, Rafid Alhallaf, Zainab Agha, et al.
Nature Communications|March 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannomaAdam P Jones, Michael J Haley, Miriam H Meadows, et al.
Pageof 14